Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
See Latest ArticlesPatients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept
British Journal of Dermatology, 07/08/09
Ortonne JP et al. - In this post-hoc analysis, patients with psoriasis who were re-treated with etanercept 25 mg twice weekly effectively recaptured clinical responses that patients found satisfactory. A flexible treatment option is available to dermatologists and patients for individualized care.
Related Articles
Pediatric psoriasis: an update
Therapeutics and Clinical Risk Management, 10/22/09
Relevance Score: 95%
FDA Approves New Drug to Treat Psoriasis
Internet Source, 11/02/09
Relevance Score: 91%
Study shows major burden of psoriasis
Internet Source, 10/29/09
Relevance Score: 91%
Prevalence of myocardial infarction in patients with psoriasis in central China
Journal of the European Academy of Dermatology and Venereology, 10/27/09
Relevance Score: 91%
Why nail psoriasis remains difficult to treat
Dermatology in Practice, 10/12/09
Relevance Score: 91%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Pharmacotherapy of regional melanoma therapy
Expert Opinion in Pharmacotherapy, 12/14/09
Dapsone hypersensitivity syndrome in non-leprosy patients: A retrospective study of its incidence in a tertiary referral center in Taiwan
Journal of Dermatological Treatment , 12/11/09
Muscle Weakness After Repeated Injection of Botulinum Toxin Type A Evaluated According to Bite Force Measurement of Human Masseter Muscle
Dermatologic Surgery, 12/10/09
Today in Psoriasis...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
Archives of Drug Information, 12/08/09
Analysis of psoriatic patients registered in Asahikawa Medical College Hospital from 1983 to 2007
Journal of Dermatology, 12/08/09
Modulation of extracellular matrix through keratinocyte-fibroblast crosstalk
Expert Review of Dermatology, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor